Victory Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158K Buy
17,689
+2,717
+18% +$21.6K ﹤0.01% 2223
2025
Q4
$90.3K Buy
14,972
+201
+1% +$1.2K ﹤0.01% 2279
2025
Q3
$84.3K Sell
14,771
-2,387
-14% -$12.2K ﹤0.01% 2310
2025
Q2
$86.5K Sell
17,158
-155,695
-90% -$835K ﹤0.01% 2340
2025
Q1
$1.12M Buy
172,853
+84,077
+95% +$748K ﹤0.01% 1749
2024
Q4
$652K Buy
88,776
+7,507
+9% +$59.2K ﹤0.01% 1956
2024
Q3
$609K Buy
81,269
+15,696
+24% +$136K ﹤0.01% 1957
2024
Q2
$584K Buy
65,573
+19,216
+41% +$184K ﹤0.01% 1930
2024
Q1
$470K Sell
46,357
-28,184
-38% -$287K ﹤0.01% 2002
2023
Q4
$750K Sell
74,541
-48,489
-39% -$443K ﹤0.01% 1842
2023
Q3
$1.15M Buy
123,030
+18,882
+18% +$269K ﹤0.01% 1583
2023
Q2
$2.55M Buy
104,148
+6,769
+7% +$170K ﹤0.01% 1331
2023
Q1
$2.27M Buy
97,379
+21,736
+29% +$556K ﹤0.01% 1366
2022
Q4
$1.91M Buy
75,643
+58,852
+350% +$1.44M ﹤0.01% 1457
2022
Q3
$324K Sell
16,791
-2,581
-13% -$65.6K ﹤0.01% 2223
2022
Q2
$493K Sell
19,372
-1,173
-6% -$27.4K ﹤0.01% 2059
2022
Q1
$418K Buy
20,545
+10,073
+96% +$299K ﹤0.01% 2190
2021
Q4
$438K Buy
10,472
+284
+3% +$11.1K ﹤0.01% 2218
2021
Q3
$443K Buy
10,188
+1,377
+16% +$59.6K ﹤0.01% 2229
2021
Q2
$417K Buy
8,811
+296
+3% +$13.5K ﹤0.01% 2293
2021
Q1
$437K Sell
8,515
-21
-0.2% -$1.13K ﹤0.01% 2257
2020
Q4
$229K Sell
8,536
-1,362
-14% -$44.3K ﹤0.01% 2349
2020
Q3
$340K Buy
9,898
+977
+11% +$42.1K ﹤0.01% 2116
2020
Q2
$365K Sell
8,921
-5,139
-37% -$172K ﹤0.01% 2097
2020
Q1
$482K Buy
+14,060
New +$378K ﹤0.01% 2104

Other funds holding VIR